The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women
NCT ID: NCT02830321
Last Updated: 2016-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2015-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Helicobacter Pylori Screening at Sohag University
NCT05835076
Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy
NCT05444439
Association of Oral Helicobacter Pylori Infection With Gastric Helicobacter Pylori Infection
NCT05790512
Association Between Helicobacter Pylori and Inflammatory Bowel Disease
NCT03820284
Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms
NCT07272681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients were divided into two groups: 46 cases of pregnant women with H.G and 44 healthy control pregnant women with no vomiting.
Both groups were matched regarding the inclusion criteria which includes maternal age (18-40 years), gestational age (\<16 wks), and signs and symptoms of H.G for cases (vomiting affecting the general condition, ketonuria, weight loss) and excluding cases or controls with multiple gestation, hyadatiform disease or maternal disease causes vomiting such as ; pyelonephritis, gastroenteritis, cholecystitis or hepatitis.
The two groups were subjected to full history taking, clinical examination, routine laboratory investigations (urine analysis, CBC, liver, kidney function tests Na, k, PT, PTT \& INR) Abdominal ultrasound was done to assess fetal life and gestational age and to exclude gestational trophoblastic disease and multiple gestation pregnancy.H.Pylori infection was assessed by using One step H.pylori Stool Antigen Test.
(CER TEST BIOTEC) pol. Industrial Rio Gallego II,Calle J, No 1, 50840, San Mateo de Gallego, Zaragoza (SPAIN) for the detection of H. pylori antigen.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case
Pregnant women who suffered from hyperemesis gravidarum and admitted in the hospital
* Age: 18-40 years old
* Gestational age: less than 16 weeks confirmed by pelvic u/s
* Excessive pregnancy - related nausea and /or vomiting that prevent adequate intake of food and fluids.
All pregnant (case and control) were asked to bring a stool sample in a clean container. Collected samples were tested in a laboratory (Ain Shams Univerisity hospital).
Stool samples were be tested by using one step H.pylori stool antigen test (CER TEST BIOTEC) for the detection of H. pylori antigen.
helicopacter pylori stool antigen test (CER TEST BIOTEC)
Stool samples were tested by using one step H.pylori stool antigen test (CER TEST BIOTEC)for the detection of H. pylori antigen in pregnant women with hyperemesis gravidarum
control
Control patients which are selected from pregnant women presenting to the outpatient clinics for routine antenatal care of the same gestational age, same age range and same socioeconomic standard as cases.
helicopacter pylori stool antigen test (CER TEST BIOTEC)
Stool samples were tested by using one step H.pylori stool antigen test (CER TEST BIOTEC)for the detection of H. pylori antigen in pregnant women with hyperemesis gravidarum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
helicopacter pylori stool antigen test (CER TEST BIOTEC)
Stool samples were tested by using one step H.pylori stool antigen test (CER TEST BIOTEC)for the detection of H. pylori antigen in pregnant women with hyperemesis gravidarum
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age: less than 16 weeks confirmed by U/S
* Excessive pregnancy - related nausea and /or vomiting that prevent adequate intake of food and fluids.
* Measuring weight loss(\>5% of pre-pregnancy weight)
* Signs of dehydration:
* Ketonuria (+1 or more)
* Hemoconcentration (normal Female hematocrit value (36.1-44.3%)
Exclusion Criteria
* Hydatidiform molar pregnancy
* Other causes of vomiting:
* Gastroentritis
* Cholecystitis
* Pyelonephritis
* Liver dysfunction
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
rasha fawzy abd el kader
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rasha fawzy abd el kader
Principal Investigator
References
Explore related publications, articles, or registry entries linked to this study.
Increased estrogen production causes decreased secretions of hydrochloric acids; therefore peptic ulcer formation or flare - up of existing peptic ulcers is uncommon during pregnancy and may improve (Winbery and Blaho, 2001).
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FDAAA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.